PubMed · 259412
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
A J Davis. 1979. Theoretically realistic.. https://pubmed.ncbi.nlm.nih.gov/259412/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
Difficult moral concerns and choices are a characteristic of palliative cancer medicine. Problems in patient information, palliative chemotherapy, treatment with unconventional remedies and clinical drug development are given as examples. The physician-scientist as member of a clinical cancer research institution particularly faces ethically troublesome situations. It is argued that next to the acquisition of bioethical competence by 'doing' staff, members working in scientific and medical frontiers should specifically be trained to identify, analyse and resolve ethical dilemmas. In conclusion, a biomedical ethics programme is presented which will be instituted at a new cancer center, comprising the establishment of a humanities research group, ethical liaison, consultation and information services as well as a system of inhouse bioethical quality control.
The sudden advent of new technological devices and sophisticated methods in both biological research and medical practice alerted different social groups to the development of unprecedented problems for moral counsel and decision-making. The field of study called bioethics grew out of religiously motivated concerns, but nowadays it attracts the attention of politicians, lawyers, religious thinkers, philosophers, scientists and doctors. Bioethics is becoming a sphere of interest to an increasing number of people. Each of these groups bring their own values, which are sometimes not in total agreement with the traditional values of medical ethics, to discussion. Therefore, the Author defends a more active participation of doctors through their representative bodies in the discussion of policies concerning the research and development of new technologies, and also the individual use of them when they are available, so that the practice of medicine may preserve the hippocratic legacy, accepting only the external influences when they are not in conflict with the intrinsic morality of medicine.